Medicine and Dentistry
Apoplexy
99%
Brain Ischemia
68%
Stenting
58%
Revascularization
43%
Endarterectomy
41%
Carotid Endarterectomy
25%
Carotid Artery Stenting
24%
Motor Performance
16%
Tissue Plasminogen Activator
13%
Cerebral Hemorrhage
12%
Clinical Trial
11%
Stenosis
10%
Carotid Disease
10%
Modified Rankin Scale
10%
Combination Therapy
10%
Large Vessel Occlusion
9%
Functional Magnetic Resonance Imaging
9%
Artery Occlusion
9%
Percutaneous Transluminal Angioplasty
8%
Myocardial Infarction
8%
Cerebrovascular Disease
8%
Disease Burden
8%
Placebo
8%
Secondary Prevention
8%
Restenosis
8%
Progenitor Cell
8%
Arm
8%
Thrombus Aspiration
8%
Randomized Controlled Trial
8%
Epileptic Seizure
8%
Subluxation
8%
Patient Population
8%
Upper Limb
8%
Percutaneous Thrombectomy
8%
Low Level Laser Therapy
8%
Thrombectomy
8%
Intracranial Stenosis
8%
Moyamoya Disease
8%
Shoulder Girdle
8%
Transient Ischemic Attack
8%
Treatment Effect
7%
National Institutes of Health Stroke Scale
6%
Mortality Rate
6%
Systolic Blood Pressure
5%
Low Density Lipoprotein Cholesterol
5%
Hazard Ratio
5%
Randomized Clinical Trial
5%
Kaplan Meier Method
5%
Keyphrases
Acute Stroke Therapy
16%
Chronic Ischemic Stroke
16%
Randomized Trial
9%
Functional Magnetic Resonance Imaging
8%
Angiotensin Receptor Blockers
8%
Quality of Life
8%
Randomized Controlled Trial
8%
Post-stroke Epilepsy
8%
Effectiveness Study
8%
Glenohumeral Subluxation
8%
Transcranial Laser Therapy
8%
Stroke Prevention
8%
Transcranial Alternating Current Stimulation (tACS)
8%
Rotating Permanent Magnet
8%
Functional Reorganization
8%
Cardiovascular Events
8%
Intracerebral Hemorrhage Stroke
8%
Aspiration Thrombectomy
8%
Intravenous Alteplase
8%
Carotid Endarterectomy
8%
Cortical Circuits
8%
Diverse Patient Population
8%
Translational Research
8%
Intolerant
8%
Stroke Patients
8%
Cerebral Small Vessel Disease Burden
8%
Carotid Disease
8%
Carotid Revascularization
8%
Clinical High Risk
8%
Clinical Practice
8%
Brain Attack
8%
Stroke Care
8%
Telmisartan
8%
Early CT
8%
Upper Limb Rehabilitation
8%
Carotid Stenting
8%
Angiotensin-converting Enzyme Inhibitor (ACEi)
8%
Medical Groups
8%
Motor Recovery
8%
Intracranial Artery Stenosis
8%
Endarterectomy
8%
Transcranial
8%
Mobile Stroke Unit
8%
Moyamoya Disease
8%
Comprehensive Stroke Center
8%
Myocardial Infarction
5%
Efficacy Endpoint
5%
Clinical Scales
5%
Active Treatment
5%
Motor Function
5%
Neuroscience
Cerebrovascular Accident
100%
Brain Ischemia
72%
Cerebral Hemorrhage
28%
Stenosis
19%
Alteplase
16%
Cerebrovascular Disease
15%
Functional Magnetic Resonance Imaging
13%
Placebo
11%
Aspirin
9%
Glycine Antagonists
9%
Tissue Plasminogen Activator
9%
Thrombolytic Drug
8%
Neuroprotection
8%
Magnetic Resonance Imaging
8%
Intracranial Stenosis
8%
Neuroprotective Agent
5%
Adverse Effect
5%
Transcranial Magnetic Stimulation
5%
